Kamal Therapeutics, Inc.
Hingham, MA
- UEI
- PEB8K1DDELY5
- CAGE
- 8XU76
- Primary NAICS
- Not on record
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 66 Clubhouse Dr, Hingham, MA 02043, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Development of human recombinant decorin core protein as an anti-scarring therapeutic for dystrophic epidermolysis… | Defense Health Agency | $2,991,032 |
Quick answers
Is Kamal Therapeutics, Inc. registered in SAM.gov?
Yes. Kamal Therapeutics, Inc.'s SAM.gov registration is active through June 12, 2027.
What is Kamal Therapeutics, Inc.'s most recent federal award?
Kamal Therapeutics, Inc.'s most recent federal grant award is Development of human recombinant decorin core protein as an anti-scarring therapeutic for dystrophic epidermolysis… (W81XWH1910834), from Defense Health Agency, on September 30, 2019.
On GovTribe
See Kamal Therapeutics, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors